Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Song

Showing results (41-50 of 98) with videos related to

Pageof 10
Sort By:
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|October 3, 2022
A Consensus Diagnosis Utilizing Surface KI-67 Expression as an Ancillary Marker in Low-Grade Dysplasia Helps Identify Patients at High Risk of Progression to High-Grade Dysplasia and Esophaegal AdenocarcinomaChristina Lee, Umar Hayat, Kevin Song, et al.
Leukemia|March 9, 2024
Redefining high risk multiple myeloma with an APOBEC/Inflammation-based classifierSarah Grasedieck, Afsaneh Panahi, Matthew C Jarvis, et al.
British Journal of Anaesthesia|December 3, 2025
Transversus abdominis plane block for postoperative pain management and opioid sparing: a systematic review and meta-analysis of randomised controlled trialsJoe Zako, Alexander Kevorkov, Sean D Jeffries, et al.
Cancer Medicine|October 13, 2020
Continuous lenalidomide and low-dose dexamethasone in patients with transplant-ineligible newly diagnosed MM: FIRST trial subanalysis of Canadian/US patientsAndrew Belch, Nizar Bahlis, Darrell White, et al.
British Journal of Haematology|November 6, 2021
The future of myeloma research in Canada and beyond: results of a James Lind Alliance priority setting partnershipSamantha Fowler, Lauren McLaughlin, Sarah Bridges, et al.
Research Involvement and Engagement|July 29, 2023
How should multiple myeloma research change in a patient-oriented world? Findings and lessons from the pan-Canadian myeloma priority setting partnershipSarah Bridges, Samantha Fowler, Lauren McLaughlin, et al.
Leukemia & Lymphoma|August 27, 2016
Comparison of a pediatric-inspired treatment protocol versus standard-intensity chemotherapy for young adults with standard-risk BCR-ABL negative acute lymphoblastic leukemiaDavid Kliman, Michael Barnett, Raewyn Broady, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2018
Improving Revised International Prognostic Scoring System Pre-Allogeneic Stem Cell Transplantation Does Not Translate Into Better Post-Transplantation Outcomes for Patients with Myelodysplastic Syndromes: A Single-Center ExperienceMusa Alzahrani, Maryse Power, Yasser Abou Mourad, et al.
British Journal of Haematology|February 9, 2021
Real-world outcomes with bortezomib-containing regimens and lenalidomide plus dexamethasone for the treatment of transplant-ineligible multiple myeloma: a multi-institutional report from the Canadian Myeloma Research Group databaseVictor H Jimenez-Zepeda, Christopher Venner, Arleigh McCurdy, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 24, 2020
Tattoos and Hematologic Malignancies in British Columbia, CanadaFreda M Warner, Maryam Darvishian, Terry Boyle, et al.
Pageof 10

Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|October 3, 2022
A Consensus Diagnosis Utilizing Surface KI-67 Expression as an Ancillary Marker in Low-Grade Dysplasia Helps Identify Patients at High Risk of Progression to High-Grade Dysplasia and Esophaegal AdenocarcinomaChristina Lee, Umar Hayat, Kevin Song, et al.
Leukemia|March 9, 2024
Redefining high risk multiple myeloma with an APOBEC/Inflammation-based classifierSarah Grasedieck, Afsaneh Panahi, Matthew C Jarvis, et al.
British Journal of Anaesthesia|December 3, 2025
Transversus abdominis plane block for postoperative pain management and opioid sparing: a systematic review and meta-analysis of randomised controlled trialsJoe Zako, Alexander Kevorkov, Sean D Jeffries, et al.
Cancer Medicine|October 13, 2020
Continuous lenalidomide and low-dose dexamethasone in patients with transplant-ineligible newly diagnosed MM: FIRST trial subanalysis of Canadian/US patientsAndrew Belch, Nizar Bahlis, Darrell White, et al.
British Journal of Haematology|November 6, 2021
The future of myeloma research in Canada and beyond: results of a James Lind Alliance priority setting partnershipSamantha Fowler, Lauren McLaughlin, Sarah Bridges, et al.
Research Involvement and Engagement|July 29, 2023
How should multiple myeloma research change in a patient-oriented world? Findings and lessons from the pan-Canadian myeloma priority setting partnershipSarah Bridges, Samantha Fowler, Lauren McLaughlin, et al.
Leukemia & Lymphoma|August 27, 2016
Comparison of a pediatric-inspired treatment protocol versus standard-intensity chemotherapy for young adults with standard-risk BCR-ABL negative acute lymphoblastic leukemiaDavid Kliman, Michael Barnett, Raewyn Broady, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2018
Improving Revised International Prognostic Scoring System Pre-Allogeneic Stem Cell Transplantation Does Not Translate Into Better Post-Transplantation Outcomes for Patients with Myelodysplastic Syndromes: A Single-Center ExperienceMusa Alzahrani, Maryse Power, Yasser Abou Mourad, et al.
British Journal of Haematology|February 9, 2021
Real-world outcomes with bortezomib-containing regimens and lenalidomide plus dexamethasone for the treatment of transplant-ineligible multiple myeloma: a multi-institutional report from the Canadian Myeloma Research Group databaseVictor H Jimenez-Zepeda, Christopher Venner, Arleigh McCurdy, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 24, 2020
Tattoos and Hematologic Malignancies in British Columbia, CanadaFreda M Warner, Maryam Darvishian, Terry Boyle, et al.
Pageof 10